Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Corey

Showing results (71-80 of 222) with videos related to

Pageof 23
Sort By:
Plos One|November 9, 2013
Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodelingHolly M Nguyen, Nazanin Ruppender, Xiaotun Zhang, et al.
Neoplasia (New York, N.Y.)|November 3, 2009
HE3235 inhibits growth of castration-resistant prostate cancerTheodore D Koreckij, Richard J Trauger, Robert Bruce Montgomery, et al.
International Journal of Cancer|September 28, 2016
Paracrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironmentAmy A Lubik, Mannan Nouri, Sarah Truong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Basic mechanisms responsible for osteolytic and osteoblastic bone metastasesTheresa A Guise, Khalid S Mohammad, Gregory Clines, et al.
Oncotarget|November 5, 2017
Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancerHong Pan, Keith H Jansson, Michael L Beshiri, et al.
Cancer Biology & Therapy|February 21, 2022
Small extracellular vesicle-mediated <i>ITGB6</i> siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient prostate cancer cellsShiv Ram Krishn, Vaughn Garcia, Nicole M Naranjo, et al.
Clinical & Experimental Metastasis|February 14, 2016
Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancerMaija P Valta, Hongjuan Zhao, Matthias Saar, et al.
Scientific Reports|June 26, 2021
MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancerEn-Chi Hsu, Michelle Shen, Merve Aslan, et al.
American Journal of Clinical Pathology|November 7, 2017
Rapid Loss of RNA Detection by In Situ Hybridization in Stored Tissue Blocks and Preservation by Cold Storage of Unstained SlidesJavier A Baena-Del Valle, Qizhi Zheng, Jessica L Hicks, et al.
Cancer Research|June 23, 2023
Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM ComplexMichael D Nyquist, Ilsa M Coleman, Jared M Lucas, et al.
Pageof 23

Showing results (71-80 of 222) with videos related to

Sort By:
Pageof 23
Plos One|November 9, 2013
Cabozantinib inhibits growth of androgen-sensitive and castration-resistant prostate cancer and affects bone remodelingHolly M Nguyen, Nazanin Ruppender, Xiaotun Zhang, et al.
Neoplasia (New York, N.Y.)|November 3, 2009
HE3235 inhibits growth of castration-resistant prostate cancerTheodore D Koreckij, Richard J Trauger, Robert Bruce Montgomery, et al.
International Journal of Cancer|September 28, 2016
Paracrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironmentAmy A Lubik, Mannan Nouri, Sarah Truong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Basic mechanisms responsible for osteolytic and osteoblastic bone metastasesTheresa A Guise, Khalid S Mohammad, Gregory Clines, et al.
Oncotarget|November 5, 2017
Gambogic acid inhibits thioredoxin activity and induces ROS-mediated cell death in castration-resistant prostate cancerHong Pan, Keith H Jansson, Michael L Beshiri, et al.
Cancer Biology & Therapy|February 21, 2022
Small extracellular vesicle-mediated <i>ITGB6</i> siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient prostate cancer cellsShiv Ram Krishn, Vaughn Garcia, Nicole M Naranjo, et al.
Clinical & Experimental Metastasis|February 14, 2016
Spheroid culture of LuCaP 136 patient-derived xenograft enables versatile preclinical models of prostate cancerMaija P Valta, Hongjuan Zhao, Matthias Saar, et al.
Scientific Reports|June 26, 2021
MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancerEn-Chi Hsu, Michelle Shen, Merve Aslan, et al.
American Journal of Clinical Pathology|November 7, 2017
Rapid Loss of RNA Detection by In Situ Hybridization in Stored Tissue Blocks and Preservation by Cold Storage of Unstained SlidesJavier A Baena-Del Valle, Qizhi Zheng, Jessica L Hicks, et al.
Cancer Research|June 23, 2023
Supraphysiological Androgens Promote the Tumor Suppressive Activity of the Androgen Receptor through cMYC Repression and Recruitment of the DREAM ComplexMichael D Nyquist, Ilsa M Coleman, Jared M Lucas, et al.
Pageof 23